Atrás
55
31
38
También listada como
NVSEF
OTC
Rango del Día
$146.93
$149.15
Rango de 52 Semanas
$97.72
$170.46
Volumen
1,563,123
Promedio 50D / 200D
$154.83
/
$133.11
Cierre Anterior
$146.03
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Healthcare (626 pares)
| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | 20.4 | 0.4 |
| P/B | 6.2 | 2.9 |
| ROE % | 31.2 | 3.7 |
| Net Margin % | 25.6 | 3.8 |
| Rev Growth 5Y % | 5.7 | 10.0 |
| D/E | 0.8 | 0.2 |
Precio Objetivo de Analistas
Hold
$127.00
-14.2%
Low: $112.00
High: $143.00
P/E Futuro
16.8
EPS Futuro
$8.81
Crecimiento EPS (est.)
+0.0%
Ingresos Est.
57 B
Estimaciones de Ganancias
| Período | EPS Est. | Ingresos Est. | Analistas |
|---|---|---|---|
| FY2030 |
$12.56
$12.04 – $13.08
|
69 B | 6 |
| FY2029 |
$11.54
$11.06 – $12.02
|
66 B | 6 |
| FY2028 |
$10.63
$10.19 – $11.07
|
64 B | 7 |
Puntos Clave
Revenue grew 5.66% annually over 5 years — modest growth
Earnings grew 17.71% over the past year
ROE of 31.17% indicates high profitability
Net margin of 25.64% shows strong profitability
Generating 17.69B in free cash flow
PEG of 0.85 suggests growth is underpriced
Crecimiento
Revenue Growth (5Y)
5.66%
Revenue (1Y)5.97%
Earnings (1Y)17.71%
FCF Growth (3Y)22.92%
Calidad
Return on Equity
31.17%
ROIC15.40%
Net Margin25.64%
Op. Margin31.15%
Seguridad
Debt / Equity
0.80
Current Ratio1.12
Interest Coverage14.38
Valoración
P/E Ratio
20.37
P/B Ratio6.21
EV/EBITDA18.27
Dividend Yield0.03%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 5.97% | Revenue Growth (3Y) | 8.38% |
| Earnings Growth (1Y) | 17.71% | Earnings Growth (3Y) | -2.71% |
| Revenue Growth (5Y) | 5.66% | Earnings Growth (5Y) | -12.54% |
| Profitability | |||
| Revenue (TTM) | 54.81B | Net Income (TTM) | 14.06B |
| ROE | 31.17% | ROA | 12.16% |
| Gross Margin | 75.02% | Operating Margin | 31.15% |
| Net Margin | 25.64% | Free Cash Flow (TTM) | 17.69B |
| ROIC | 15.40% | FCF Growth (3Y) | 22.92% |
| Safety | |||
| Debt / Equity | 0.80 | Current Ratio | 1.12 |
| Interest Coverage | 14.38 | Dividend Yield | 0.03% |
| Valuation | |||
| P/E Ratio | 20.37 | P/B Ratio | 6.21 |
| P/S Ratio | 5.22 | PEG Ratio | 0.85 |
| EV/EBITDA | 18.27 | Dividend Yield | 0.03% |
| Market Cap | 286.27B | Enterprise Value | 311.87B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 54.81B | 51.72B | 46.66B | 43.46B | 43.97B |
| Net Income | 14.06B | 11.94B | 14.85B | 6.96B | 24.02B |
| EPS (Diluted) | 7.19 | 5.87 | 7.10 | 3.17 | 10.63 |
| Gross Profit | 41.12B | 38.90B | 34.19B | 31.88B | 32.24B |
| Operating Income | 17.07B | 14.54B | 9.77B | 7.95B | 10.06B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 115.57B | 102.25B | 99.95B | 117.45B | 131.80B |
| Total Liabilities | 69.02B | 58.12B | 53.20B | 58.03B | 63.97B |
| Shareholders' Equity | 46.13B | 44.05B | 46.67B | 59.34B | 67.66B |
| Total Debt | 37.03B | 31.26B | 26.35B | 27.91B | 31.03B |
| Cash & Equivalents | 11.44B | 11.46B | 13.39B | 7.52B | 12.41B |
| Current Assets | 30.46B | 29.70B | 30.48B | 36.91B | 45.72B |
| Current Liabilities | 27.28B | 28.69B | 26.39B | 28.66B | 30.21B |
Puntuaciones de Estrategias
This stock passed the criteria for 3 strategies
Score = fit strength (0–100)
Rank = position among all matches
Custom
Cash Flow Compounder
#301 of 1024
Custom
Capital Light Compounder
#151 of 213
Growth + Value
Growth at a Reasonable Price (Peter Lynch)
#255 of 326
Actividad Reciente
Entró
Cash Flow Compounder
Mar 24, 2026
Entró
Capital Light Compounder
Mar 24, 2026
Entró
Growth at a Reasonable Price (Peter Lynch)
Mar 24, 2026